BioSpace News Archive

Nestle and Nuritas have entered into a collaboration aiming at discovering bioactive peptide networks within specific target areas of significant value.

Vectura Group plans to announce its Preliminary Results for the 12 months ended 31 December 2017 on Wednesday 21 March 2018.

Management will conduct a conference call and audio webcast on Wednesday, February 14, 2018 at 8:30 a.m. Eastern Time to discuss these results.

The aim is to prove the overall healthcare benefits of testing hereditary pancreatic cancer patients.

The joimax announces very strong sales figures for 2017.

Cosentyx is currently the only fully human IL-17A antagonist to demonstrate efficacy and safety in a dedicated Phase IIIb study of scalp psoriasis.

Net sales amounted to SEK 170.1 million, an increase of 23%.

Enamine and BioSolveIT announced the launch of the ‘REAL Space Navigator’. Jointly developed, the new software tool capitalizes on Enamine’s REAL (readily accessible) virtual compound concept and provides efficient ‘search & find’ access to more than 640 million pharma-oriented molecules, to date the world’s largest chemical space of commercially accessible compounds.

An investor conference call will be held at 8:00 a.m. (ET) on Thursday, February 22, 2018.

Medidata announced today that its virtual trials platform, Engage, is now being offered as a part of the Medidata Clinical Cloud, providing researchers unmatched flexibility to conduct clinical trials virtually, on-site, or as a hybrid.